Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September 2012 Volume 4 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September 2012 Volume 4 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines

  • Authors:
    • Chong Yan
    • Chibo Liu
    • Qiaozhi Jin
    • Zhihai Li
    • Baohong Tao
    • Zhiyi Cai
  • View Affiliations / Copyright

    Affiliations: Department of Otolaryngology - Head and Neck Surgery, Taizhou Municipal Hospital, Taizhou, Zhejiang 318000, P.R. China, Department of Clinical Laboratory, Taizhou Municipal Hospital, Taizhou, Zhejiang 318000, P.R. China
  • Pages: 505-508
    |
    Published online on: June 19, 2012
       https://doi.org/10.3892/ol.2012.763
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of this study was to investigate the mRNA and protein expression levels of the Syk gene as well as its promoter methylation in nasopharyngeal carcinoma (NPC) cell lines. The CNE-1 (highly differentiated), CNE-2 (poorly differentiated) and NP69 (non-cancerous human immortalized nasopharyngeal epithelial cells) cell lines were used in the present study. The MS-PCR, Q-RT-PCR and western blotting methods were used to examine the Syk gene promoter methylation levels and mRNA and protein expression in the three cell lines. The promoter methylation levels in CNE-1, CNE-2 and NP69 cells were 36%, 62% and 0, respectively. The mRNA levels in CNE-1 and CNE-2 cells were 42±3.5 and 28±2% of that in NP69, respectively; the protein levels in CNE-1 and CNE-2 cells were 36±4.5 and 16±2.5 of that in NP69, respectively; the statistical differences between groups were significant. The lower differentiation levels of the NPC cell lines correlate with lower levels of mRNA and protein expression of the Syk gene, as well as higher promoter methylation levels.

Introduction

Nasopharyngeal carcinoma (NPC) is one of the most common types of malignant cancer, with a high occurrence rate in the Chinese population compared with the western population (1). The genetic mechanisms of oncogenesis include the inactivation of tumor suppression genes, such as p53, Rb and p16, as well as the overexpression of oncogenes, such as bcl-2, ras and Cyclin D1. However, the mutations of these genes are rare in NPC patients. One possibility is that the regulation of gene expression through promoter methylation is changed in NPC cases (2,3). The present study aimed to examine the differences in the mRNA and protein expression levels of the Syk gene as well as its promoter methylation in NPC cell lines with different differentiation levels, to understand the potential contribution of promoter methylation to NPC genesis.

Materials and methods

Materials

The NPC cell lines CNE-1, CNE-2 and NP69 were purchased from Yingrun Biotechnol Co. (Shanghai, China). The following reagents and instruments were used: Q-RT-PCR machine (ABI, Applied Biosystems, Carlsbad, CA, USA), Q-RT-PCR kit (Tiangen, Shanghai, China), keratinocyte-sfm culture medium (Invitrogen, Carlsbad, CA, USA), Genomic DNA extraction and purification kit, rabbit anti-β-actin, goat anti-rabbit secondary antibody, PVDF membrane, ECL kit (Kaiji Biotechnology, Shanghai, China).

Cell culture

The cell culture of the CNE-1, CNE-2 and NP69 cell lines was performed with complete RPMI-1640 medium at 37°C in a 5% CO2 incubator. The cells were digested with 0.25% trypsin protease-EDTA.

MS-PCR

Following the DNA extraction, 8 μg total DNA with ddH2O in a total volume of 18 μl was heated at 95°C and then immediately placed into an ice water bath. NaOH (3 M) was added for denaturation at 42°C for 20 min and the solution was then mixed with freshly prepared hydroquinone and sodium bisulfite. Liquid paraffin (200 μl) was added and incubated at 50°C for 16 h. The liquid paraffin was then removed. The water phase was mixed with a purified solution of TBE buffer before de-salting with Wizard DNA purification system. An isopropanol wash was performed twice and DNA was eluted into 50 μl ddH2O, then centrifuged before being incubated with 3 M NaOH at 37°C for 15 min for denaturation. Then 33 μl of 10 M ammonium acetate was added to buffer the NaOH before the ethanol was added to precipitate the DNA at -70°C for 1 h. Then the tube was centrifuged at 4°C at 10,000 × g for 20 min. The DNA was washed with 70% ethanol after removing the supernatant. Finally the DNA was diluted in 50 μl TE buffer and stored at -20°C. For the MS-PCR detection, methylation-specific primers contained 9 CpG islands and non-methylation-specific primers contained 8 CpG islands. The reaction was performed as follows: methylation system: denaturation at 95°C for 5 min, then 50 cycles of 95°C for 10 sec, annealing at 60°C for 15 sec and extension at 72°C for 25 sec; non-methylation system: denaturation at 95°C for 5 min, then 50 cycles of 95°C for 30 sec, annealing at 60°C for 15 sec and extension at 72°C for 25 sec; with a final step at 72°C for 10 min. PCR products (5 μl) were used for 2% agarose gel electrophoresis and the image was analyzed for semi-quantitative absorbance values in order to calculate the methylation ratio [methylated primer band absorbance value/(methylated primer extension increase in absorbance values + non-methylated primer band absorbance) × 100%]. The sequences of the primers are listed in Table I.

Table I

Sequences of methylation and non-methylation primers for the Syk gene promoter.

Table I

Sequences of methylation and non-methylation primers for the Syk gene promoter.

PrimerSequencesLength (bp)
MethylationF: 5′-TTTCGGGTTTATGGGCGCGG-3′
R: 5′-ACGAAAACGAACGCAACGCGAA-3′
202
Non-methylationF: 5′GTTTTAGTTGATTTTTGTTTAGTTTTG-3′
R: 5′-ACCACCCACTCCTCCTCACT-3′
202

[i] F, upstream primer; R, downstream primer.

Q-RT-PCR

RNA extraction was performed using the TRIzol approach with suspended cells and the purity was tested with the UV spectrophotometer A260/A280 ratio between 1.8 and 2.1. The 18 S and 28 S integrity were analyzed with agarose gel electrophoresis. For the cDNA synthesis reaction system, 2 μg RNA was mixed with 10× RT mix, dNTP mix, 2 μl Oligo-dT15, 1 μl Quant Reverse Transcriptase and RNase Free ddH2O to a final volume of 20 μl. The mixture was incubated at 37°C for 60 min. The SYBR-Green fluorescence dye was used during the real-time PCR. The 20-μl reaction system included 9 μl 2.5× Real Master mix/20× SYBR solution mixed reaction solution, 2 μl cDNA solution, 2 μl upstream and downstream primers (100 nM) and ddH2O was added to make a final volume of 20 μl. Each sample was repeated 3 times. The reaction conditions were: pre-denaturation at 95°C for 2 min, then 40 cycles of 95°C for 15 sec, 62°C for 30 sec, 68°C for 60 sec; final reaction at 95°C for 15 sec and 60°C for 1 min, then 95°C for 15 sec. The fluorescence signals were collected for the melting curve analysis. The Ct value was recorded in the three repeated experiments and averaged, then calculated using the comparative ΔΔCt method. The sequences of primers are listed in Table II.

Table II

Sequences of Syk gene and GAPDH gene primers.

Table II

Sequences of Syk gene and GAPDH gene primers.

GeneSequencesLength (bp)
SykF: 5′-CAT GTC AAG GAT AAG AAC ATC ATA GA-3′
R: 5′-AGT TCA CCA CGT CAT AGT AGT AAT T-3′
514
GAPDHF: 5′-ATG GCC TTC CGT GTC CCC ACT G-3′
R: 5′-TGA GTG TGG CAG GGA CTC CCC A-3′
398

[i] F, upstream primer; R, downstream primer.

Western blot analysis

The total protein samples were transferred to PVDF membranes (positively charged Heni dragon film) following SDS-PAGE. The blocking was performed with 5% non-fat milk powder and the primary antibody was incubated at 4°C overnight. The incubation with the secondary antibody was performed at room temperature for 1 h prior to washing and ECL treatment and finally the X-ray film was developed. GADPH was used as an internal control. The image analysis system was used to find the absorbance value ratio between Syk and GADPH.

Statistical analysis

The SPSS 17.0 software was used for statistical analysis and the data are presented as mean ± standard deviation. The single factor analysis of variance was used to compared the Syk promoter methylation rate and mRNA and protein expression differences among the cell lines. P<0.05 was considered to indicate a statistically significant result.

Results

Promoter methylation in different cell lines

The electrophoresis results of the MS-PCR products suggest that CNE-1 and CNE-2 cells showed incomplete Syk promoter methylation (amplification with both groups of primers), while the NP69 cell line showed no promoter methylation (Fig. 1A). The methylation rates in CNE-1 and CNE-2 cells were statistically different at 36 and 62%, respectively (Fig. 1B; P<0.01).

Figure 1

(A) MS-PCR electrophoresis image of the three cell lines. (B) Different methylation rate of the two NPC cell lines [(M/M+U) × 100%)]. M, methylated primer band absorbance; U, non-methylated primer band absorbance.

Syk mRNA expression in different cell lines

The melting curves of the Syk and GAPDH genes had single peaks at 80.57°C and 88.73°C, respectively, suggesting high primer specificity. The results of quantitative study of Syk gene expression are shown in Fig. 2. The mRNA was expressed in all three cell lines. The mRNA levels in CNE-1 and CNE-2 cells were lower, 42±3.5 and 28±2% of that in NP69, respectively; the differences between the groups were statistically significant (P<0.01).

Figure 2

Syk mRNA expression levels in different cell lines (normalized to NP69).

Syk protein expression in different cell lines

The results of the western blot analysis of Syk protein expression are shown in Fig. 3A. The protein was expressed in all three cell lines. The protein levels in CNE-1 and CNE-2 cells were lower, 36±4.5 and 16±2.5% of that in NP69 (Fig. 3B), respectively; the differences between the groups were statistically significant (P<0.01).

Figure 3

(A) Results of western blot analysis of the Syk protein. (B) Syk protein expression levels in different cell lines (normalized to NP69).

Discussion

The epigenetic theory of cancer has emerged as a hot spot in recent years, especially for tumor suppressor genes (4,5). The present study used NPC as the model to investigate the epigenetic changes of tumor suppressor genes. Syk is a non-receptor tyrosine kinase which was first identified in 1991 (6) and locates to the q22 region of human chromosome 9. The protein contains 629 amino acids and has a molecular weight of 72 kDa. Syk is a significant molecule in the B cell antigen-receptor signaling pathway, and is considered to be a candidate tumor suppressor gene, the loss of which results in the retarded development and maturation of immune cells or even severe combined immunodeficiency (SCID) (7,8). This may lead to the failure of monitoring cancer cell development and finally tumor growth.

The present study used NPC cells lines with varied levels of differentiation with NP69 as the control to examine the changes in the expression of the Syk gene and correlated changes in epigenetic control. The results revealed that the mRNA expression level in NP69 cells was higher than that in the NPC cell lines (P<0.01) and that in CNE-1 cells the mRNA expression level was higher than that in CNE-2 cells (P<0.01), suggesting a positive correlation between mRNA expression and the differentiation level; similar results were also observed for Syk protein expression. Finally, the methylation level of the Syk gene promoter was negatively correlated with the differentiation level.

Previous studies have suggested that the tumor suppression function of Syk is due to its inhibition of cell proliferation and migration, with the downregulation of its expression in breast, gastric, colorectal and liver cancer, among others (8–10). The detailed roles of Syk in NPC growth and metastasis are not clear. Recent studies have highlighted the roles of epigenetic changes of tumor suppressor genes in oncogenesis (2,4,11,12). Our results are consistent with this theory, and the low differentiation level was associated with a low expression level of Syk and high methylation level of the promoter region. Further study is needed to elucidate the mechanism by which promoter methylation contributes to the altered expression of the Syk gene in NPC cell lines.

References

1 

Tao Q and Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med. 9:1–24. 2007.PubMed/NCBI

2 

Li LL, Shu XS, Wang ZH, Cao Y and Tao Q: Epigenetic disruption of cell signaling in nasopharyngeal carcinoma. Chin J Cancer. 30:231–239. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Lo KW and Huang DP: Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol. 12:451–462. 2002. View Article : Google Scholar : PubMed/NCBI

4 

Niller HH, Wolf H and Minarovits J: Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin Cancer Biol. 19:158–164. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Buchholz TA and Wazer DE: Molecular biology and genetics of breast cancer development: a clinical perspective. Semin Radiat Oncol. 12:285–295. 2002. View Article : Google Scholar : PubMed/NCBI

6 

Taniguchi T, Kobayashi T, Kondo J, et al: Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem. 266:15790–15796. 1991.PubMed/NCBI

7 

Medves S and Demoulin JB: Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies. J Cell Mol Med. 16:237–248. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Stewart ZA and Pietenpol JA: Syk: a new player in the field of breast cancer. Breast Cancer Res. 3:5–7. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Efremov DG and Laurenti L: The Syk kinase as a therapeutic target in leukemia and lymphoma. Expert Opin Investig Drugs. 20:623–636. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Page TH, Smolinska M, Gillespie J, Urbaniak AM and Foxwell BM: Tyrosine kinases and inflammatory signalling. Curr Mol Med. 9:69–85. 2009. View Article : Google Scholar

11 

Simons MJ: Nasopharyngeal carcinoma as a paradigm of cancer genetics. Chin J Cancer. 30:79–84. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Hutajulu SH, Indrasari SR, Indrawati LP, et al: Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer. 10:482011. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yan C, Liu C, Jin Q, Li Z, Tao B and Cai Z: The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines. Oncol Lett 4: 505-508, 2012.
APA
Yan, C., Liu, C., Jin, Q., Li, Z., Tao, B., & Cai, Z. (2012). The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines. Oncology Letters, 4, 505-508. https://doi.org/10.3892/ol.2012.763
MLA
Yan, C., Liu, C., Jin, Q., Li, Z., Tao, B., Cai, Z."The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines". Oncology Letters 4.3 (2012): 505-508.
Chicago
Yan, C., Liu, C., Jin, Q., Li, Z., Tao, B., Cai, Z."The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines". Oncology Letters 4, no. 3 (2012): 505-508. https://doi.org/10.3892/ol.2012.763
Copy and paste a formatted citation
x
Spandidos Publications style
Yan C, Liu C, Jin Q, Li Z, Tao B and Cai Z: The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines. Oncol Lett 4: 505-508, 2012.
APA
Yan, C., Liu, C., Jin, Q., Li, Z., Tao, B., & Cai, Z. (2012). The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines. Oncology Letters, 4, 505-508. https://doi.org/10.3892/ol.2012.763
MLA
Yan, C., Liu, C., Jin, Q., Li, Z., Tao, B., Cai, Z."The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines". Oncology Letters 4.3 (2012): 505-508.
Chicago
Yan, C., Liu, C., Jin, Q., Li, Z., Tao, B., Cai, Z."The promoter methylation of the Syk gene in nasopharyngeal carcinoma cell lines". Oncology Letters 4, no. 3 (2012): 505-508. https://doi.org/10.3892/ol.2012.763
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team